Home › FDA Advisory Committee Recommends The Approval Of Lesinurad For Gout Patients
 

Keywords :   


FDA Advisory Committee Recommends The Approval Of Lesinurad For Gout Patients

2015-11-03 04:41:07| drugdiscoveryonline Home Page

AstraZeneca recentlyannounced that the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10-4 to recommend the approval of lesinurad 200 mg tablets for the treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor (XOI)

Tags: committee approval patients advisory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.06Atlantic Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
25.06Will there be more air travel chaos this summer?
25.06Bankruptcy trustee plans to shut down Alex Jones' Infowars
25.06Eastern North Pacific Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
25.06The screen tech that can do almost anything
25.06Criminal charges recommended against Boeing
More »